Summary

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Organoids market size will reach 98.15 Million USD in 2026 and is projected to reach 401.22 Million USD by 2033, with a CAGR of 22.28% (2026-2033). Notably, the China Organoids market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Organoids are three-dimensional, miniature versions of organs or tissues that are grown in vitro (outside of the body) and mimic the structure and function of the corresponding natural organs or tissues. They are typically derived from stem cells, such as induced pluripotent stem cells (iPSCs) or adult stem cells, and are cultured in a controlled environment. Organoids have gained significant importance in biomedical research, drug development, and regenerative medicine. They allow scientists to study the development, function, and diseases of specific organs or tissues in a more biologically relevant and ethical manner than traditional cell cultures or animal models. Organoids are used to investigate diseases, test drug responses, and potentially even replace damaged or diseased tissues in the future, offering new insights and opportunities in the field of personalized medicine and healthcare.

The major global suppliers of Organoids include Thermo Fisher Scientific, Merck, Corning, STEMCELL Technologies, Lonza, Prellis Biologics, amsbio, Beijing Daxiang Biotech, Tanwang Medical, Ketu Medicine, Chuangxin International, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Organoids. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Organoids market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Organoids market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Organoids industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Organoids Include:

Thermo Fisher Scientific

Merck

Corning

STEMCELL Technologies

Lonza

Prellis Biologics

amsbio

Beijing Daxiang Biotech

Tanwang Medical

Ketu Medicine

Chuangxin International

Organoids Product Segment Include:

Stem Cell Source

Tumor Cell Source

Organoids Product Application Include:

Biopharmaceutical Companies

Hospital

Academics and Research Institutes




Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Organoids Industry PESTEL Analysis

Chapter 3: Global Organoids Industry Porter’s Five Forces Analysis

Chapter 4: Global Organoids Major Regional Market Size and Forecast Analysis

Chapter 5: Global Organoids Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Organoids Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Organoids Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Organoids Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Organoids Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Organoids Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Organoids Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Organoids Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

ページTOPに戻る

Table of Contents

Table of Contents

1 Organoids Market Overview

  1.1 Product Definition and Statistical Scope

   1.2 Organoids Product by Type

       1.2.1 Stem Cell Source

       1.2.2 Tumor Cell Source

   1.3 Organoids Product by Application

       1.3.1 Biopharmaceutical Companies

       1.3.2 Hospital

       1.3.3 Academics and Research Institutes

   1.4 Global Organoids Market Size Analysis (2021-2033)

   1.5 Organoids Market Development Status and Trends

       1.5.1 Organoids Industry Development Status Analysis

       1.5.2 Organoids Industry Development Trends Analysis

2 Organoids Market PESTEL Analysis

   2.1 Political Factors Analysis

   2.2 Economic Factors Analysis

   2.3 Social Factors Analysis

   2.4 Technological Factors Analysis

   2.5 Environmental Factors Analysis

   2.6 Legal Factors Analysis

3 Organoids Market Porter's Five Forces Analysis

   3.1 Competitive Rivalry

   3.2 Threat of New Entrants

   3.3 Bargaining Power of Suppliers

   3.4 Bargaining Power of Buyers

   3.5 Threat of Substitutes

4 Global Organoids Market Analysis by Regions

   4.1 Organoids Overall Market: 2025 VS 2026 VS 2033

   4.2 Global Organoids Revenue and Forecast Analysis (2021-2033)

       4.2.1 Global Organoids Revenue and Market Share by Region (2021-2026)

       4.2.2 Global Organoids Revenue and Market Share Forecast by Region (2027-2033)

5 Global Organoids Market Size by Type and Application

   5.1 Global Organoids Market Size by Type (2021-2033)

   5.2 Global Organoids Market Size by Application (2021-2033)

6 North America

   6.1 North America Organoids Market Size and Growth Rate Analysis (2021-2033)

   6.2 North America Key Suppliers Analysis

   6.3 North America Organoids Market Size by Type

   6.4 North America Organoids Market Size by Application

   6.5 North America Organoids Market Size by Country

       6.5.1 US

       6.5.2 Canada

7 Europe

   7.1 Europe Organoids Market Size and Growth Rate Analysis (2021-2033)

   7.2 Europe Key Suppliers Analysis

   7.3 Europe Organoids Market Size by Type

   7.4 Europe Organoids Market Size by Application

   7.5 Europe Organoids Market Size by Country

       7.5.1 Germany

       7.5.2 France

       7.5.3 United Kingdom

       7.5.4 Italy

       7.5.5 Spain

       7.5.6 Benelux

8 China

   8.1 China Organoids Market Size and Growth Rate Analysis (2021-2033)

   8.2 China Key Suppliers Analysis

   8.3 China Organoids Market Size by Type

   8.4 China Organoids Market Size by Application

9 APAC (excl. China)

   9.1 APAC (excl. China) Organoids Market Size and Growth Rate Analysis (2021-2033)

   9.2 APAC (excl. China) Key Suppliers Analysis

   9.3 APAC (excl. China) Organoids Market Size by Type

   9.4 APAC (excl. China) Organoids Market Size by Application

   9.5 APAC (excl. China) Organoids Market Size by Country

       9.5.1 Japan

       9.5.2 South Korea

       9.5.3 India

       9.5.4 Australia

       9.5.5 Southeast Asia

10 Latin America

   10.1 Latin America Organoids Market Size and Growth Rate Analysis (2021-2033)

   10.2 Latin America Key Suppliers Analysis

   10.3 Latin America Organoids Market Size by Type

   10.4 Latin America Organoids Market Size by Application

   10.5 Latin America Organoids Market Size by Country

       10.5.1 Mexico

       10.5.2 Brazil

11 Middle East & Africa

   11.1 Middle East & Africa Organoids Market Size and Growth Rate Analysis (2021-2033)

   11.2 Middle East & Africa Key Suppliers Analysis

   11.3 Middle East & Africa Organoids Market Size by Type

   11.4 Middle East & Africa Organoids Market Size by Application

   11.5 Middle East & Africa Organoids Market Size by Country

       11.5.1 Saudi Arabia

       11.5.2 South Africa

12 Competition by Suppliers

   12.1 Global Organoids Market Revenue by Key Suppliers (2021-2033)

   12.2 Organoids Competitive Landscape Analysis and Market Dynamic

       12.2.1 Organoids Competitive Landscape Analysis

       12.2.2 Global Key Suppliers Headquarter Location and Key Area Sales

       12.2.3 Market Dynamic

13 Key Companies Analysis

   13.1 Thermo Fisher Scientific

       13.1.1 Thermo Fisher Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.1.2 Thermo Fisher Scientific Organoids Product Portfolio

       13.1.3 Thermo Fisher Scientific Organoids Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.2 Merck

       13.2.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.2.2 Merck Organoids Product Portfolio

       13.2.3 Merck Organoids Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.3 Corning

       13.3.1 Corning Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.3.2 Corning Organoids Product Portfolio

       13.3.3 Corning Organoids Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.4 STEMCELL Technologies

       13.4.1 STEMCELL Technologies Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.4.2 STEMCELL Technologies Organoids Product Portfolio

       13.4.3 STEMCELL Technologies Organoids Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.5 Lonza

       13.5.1 Lonza Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.5.2 Lonza Organoids Product Portfolio

       13.5.3 Lonza Organoids Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.6 Prellis Biologics

       13.6.1 Prellis Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.6.2 Prellis Biologics Organoids Product Portfolio

       13.6.3 Prellis Biologics Organoids Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.7 amsbio

       13.7.1 amsbio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.7.2 amsbio Organoids Product Portfolio

       13.7.3 amsbio Organoids Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.8 Beijing Daxiang Biotech

       13.8.1 Beijing Daxiang Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.8.2 Beijing Daxiang Biotech Organoids Product Portfolio

       13.8.3 Beijing Daxiang Biotech Organoids Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.9 Tanwang Medical

       13.9.1 Tanwang Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.9.2 Tanwang Medical Organoids Product Portfolio

       13.9.3 Tanwang Medical Organoids Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.10 Ketu Medicine

       13.10.1 Ketu Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.10.2 Ketu Medicine Organoids Product Portfolio

       13.10.3 Ketu Medicine Organoids Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

   13.11 Chuangxin International

       13.11.1 Chuangxin International Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

       13.11.2 Chuangxin International Organoids Product Portfolio

       13.11.3 Chuangxin International Organoids Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2026)

14 Industry Chain Analysis

   14.1 Organoids Industry Chain Analysis

   14.2 Organoids Typical Downstream Customers

   14.3 Organoids Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

   16.1 Methodology/Research Approach

   16.2 Research Scope

   16.3 Benchmarks and Assumptions

   16.4 Date Source

       16.4.1 Primary Sources

       16.4.2 Secondary Sources

   16.5 Data Cross Validation

   16.6 Disclaimer